Novel Strategies for the Diagnosis and Treatment of Cardiac Amyloidosis | oneAMYLOIDOSISvoice
Scientific Articles

Novel Strategies for the Diagnosis and Treatment of Cardiac Amyloidosis

key information

source: Expert Review of Cardiovascular Therapy

year: 2015

authors: Palladini G, Milani P, Merlini G


Systemic amyloidoses are rare, complex diseases caused by misfolding of autologous protein. The presence of heart involvement is the most important prognostic determinant. The diagnosis of amyloid cardiac involvement relies on echocardiography and magnetic resonance imaging, while scintigraphy with bone tracers is helpful in differentiating light chain amyloidosis from other types of amyloidosis involving the heart. Although these diseases are fatal, effective treatments exist that can alter their natural history, provided that they are started before irreversible cardiac damage has occurred.

Refined diagnostic techniques, accurate patients’ stratification based on biomarkers of cardiac dysfunction, the availability of novel, more powerful drugs, and ultimately, the unveiling of the cellular mechanisms of cardiac damage created a favorable environment for a dramatic improvement in the treatment of this disease that we expect in the next few years.


organization: University of Pavia, Italy

DOI: 10.1586/14779072.2015.1093936

read more

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.